Physician

Roberto Guerra Del Castillo, MD

According to 2025 Medicare claims, Roberto Castillo, MD (NPI: 1003156209) practices internal medicine in the Miami-Miami Beach-Kendall, FL market, with the plurality of this provider's patient population coming from Miami-Dade, FL. This provider's primary affiliated billing organization is MREYES NP CORP (NPI: 1437997228) and primary practice location at 33142-8224. Castillo is affiliated with the Sound Physicians Long Term Care Management, LLC (ACO ID: A5220) and NeueHealth Collaborative Care LLC (ACO ID: A5513), participating under the MSSP model.

Castillo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 191 traditional Medicare patients, billed 1,004 HCPCS/CPT codes, and received $997,159 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,670 prescription claims across 290 beneficiaries totaling $194,618 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 84 claims. Open Payments data shows 5 records totaling $135. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $16,193 to $997,159. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $1,251 to $4,333.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	80	183	$16,193
2017	249	897	$61,891
2018	216	631	$50,526
2019	236	796	$64,747
2020	192	660	$58,687
2021	213	658	$58,987
2022	282	911	$70,780
2023	216	642	$53,929
2024	191	1,004	$997,159

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	93	231	$7,439
2016	201	1,339	$45,118
2017	485	6,218	$371,851
2018	666	9,991	$752,818
2019	586	8,799	$605,909
2020	405	5,567	$349,553
2021	398	3,962	$303,416
2022	361	3,004	$278,552
2023	347	2,176	$236,709
2024	290	1,670	$194,618

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	15	$106
2018	N/R	N/R	N/R
2019	N/R	41	$1,267
2020	N/R	35	$505
2021	N/R	22	$983
2022	N/R	22	$947
2023	N/R	36	$1,725
2024	N/R	84	$4,075

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	22	22	$138
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	72	189	$98
99239	Hospital discharge day management, more than 30 minutes	97	98	$91
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	106	334	$65

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	34	962	$35,886
Eliquis	Apixaban	29	1,140	$22,541
Synjardy	Empagliflozin/Metformin Hcl	14	600	$12,174
Vascepa	Icosapent Ethyl	28	995	$11,653
Xarelto	Rivaroxaban	19	541	$10,719

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	42	$3,407
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	42	$668

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$135	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Roberto Guerra Del Castillo, MD?

Tedicare shows public-source Medicare data for Roberto Guerra Del Castillo, MD (NPI 1003156209), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Roberto Guerra Del Castillo, MD have ACO affiliation data?

Roberto Guerra Del Castillo, MD is shown with ACO affiliation data for Sound Physicians Long Term Care Management, LLC (MSSP, ACO ID A5220) and NeueHealth Collaborative Care LLC (MSSP, ACO ID A5513).

What billing organization is linked to Roberto Guerra Del Castillo, MD?

Roberto Guerra Del Castillo, MD is linked to MREYES NP CORP (billing NPI 1437997228) in the available physician profile data.

Does Roberto Guerra Del Castillo, MD have Open Payments data?

Roberto Guerra Del Castillo, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.